50242-090 : Zelboraf 240 mg Oral Tablet
NDC: | 50242-090 |
Labeler: | Genentech, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Zelboraf |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | NDA202429 |
Rev. Date: |
Appearance:
Markings: | VEM |
Shapes: |
Oval |
Colors: |
Orange /
White |
Size (mm): | 19 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
NDC Package Codes:
- 50242-090-01: 1 BOTTLE, PLASTIC IN 1 CARTON (50242‑090‑01) > 120 TABLET, FILM COATED IN 1 BOTTLE, PLASTIC
- 50242-090-02: 1 BOTTLE, PLASTIC IN 1 CARTON (50242‑090‑02) > 112 TABLET, FILM COATED IN 1 BOTTLE, PLASTIC
- 50242-090-86: 1 BOTTLE, PLASTIC IN 1 CARTON (50242‑090‑86) > 112 TABLET, FILM COATED IN 1 BOTTLE, PLASTIC
Active Ingredients:
- Vemurafenib
Dosage Strength:
- 240 mg
Inactive Ingredients:
- Hypromellose Acetate Succinate 06081224 (3 Mm2/S)
- Silicon Dioxide
- Croscarmellose Sodium
- Hydroxypropyl Cellulose (Type H)
- Magnesium Stearate
- Polyvinyl Alcohol
- Titanium Dioxide
- Polyethylene Glycol 3350
- Talc
- Ferric Oxide Red
Pharmaceutical Classes:
- Kinase Inhibitor [EPC]
- Protein Kinase Inhibitors [MoA]
- Cytochrome P450 1A2 Inhibitors [MoA]
- P-Glycoprotein Inhibitors [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 50242-088Next: 50242-091 >
Related Discussions:
Vemurafenib stopped working!
I have a friend who has been on vemurafenib for the past 4 months, doctors have now found new cancer growths and have th... 1 reply
I have a friend who has been on vemurafenib for the past 4 months, doctors have now found new cancer growths and have th... 1 reply
Zelboraf/How to combat joint pain
I've been taking Zelboraf for about 2 weeks and have severe joint pain. I'm looking for a way to combat the join... 1 reply
I've been taking Zelboraf for about 2 weeks and have severe joint pain. I'm looking for a way to combat the join... 1 reply
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.